Bringing back the woolly mammoth and other extinct creatures may be impossible
By Elizabeth Pennisi,
Science
| 03. 09. 2022
An extinct rat that once lived on an island in the Indian Ocean may have put the kibosh on scientists’ dreams of resurrecting more famous extinct animals like the woolly mammoth. The Christmas Island rat disappeared just over 100 years ago, but researchers now say even its detailed genome isn’t complete enough to bring it back to life.
The work “shows both how wonderfully close—and yet—how devastatingly far” scientists are from being able to bring back extinct species by genetically transforming a close relative in what’s called “de-extinction,” says Douglas McCauley, an ecologist at the University of California, Santa Barbara, who was not involved with the study.
No species has yet been revived, but de-extinction appeals to many geneticists and futurists. “I know a lot of biologists who think, ‘Can I do this?’” says Karen Wendling, an ethicist at the University of Guelph. Part of the fascination is simply the promise of seeing a vanished species come to life. But putting a key animal back into its original...
Related Articles
Not the species, certainly, but the Institute of that name, which was founded by transhumanist philosopher Nick Bostrom in 2005 as a research group at Oxford University. According to a recently posted Final Report, its goal was “to pursue the big questions in a transdisciplinary way” by pulling together “researchers from disciplines such as philosophy, computer science, mathematics, and economics.” This evolved before long into the study and promotion of “effective altruism” and “longtermism” as...
By Tristan Manalac, BioSpace | 04.02.2024
Verve Therapeutics has suspended enrollment in the Phase Ib Heart-1 study evaluating its lead gene editing program VERVE-101 following a serious adverse event, the company announced Tuesday.
A patient, who received a 0.45-mg/kg dose of VERVE-101, developed a grade 3...
By Timnit Gebru and Émile P. Torres, First Monday | 04.14.2024
The stated goal of many organizations in the field of artificial intelligence (AI) is to develop artificial general intelligence (AGI), an imagined system with more intelligence than anything we have ever seen. Without seriously questioning whether such a system can...
By Harold Brubaker, The Philadelphia Inquirer | 04.04.2024
Acompany started by University of Pennsylvania scientist Jim Wilson has received FDA approval to test a form of gene editing in infants for the first time in the United States, the company said Thursday.
The Plymouth Meeting company, iECURE, is...